kava and Systemic-Inflammatory-Response-Syndrome

kava has been researched along with Systemic-Inflammatory-Response-Syndrome* in 3 studies

3 other study(ies) available for kava and Systemic-Inflammatory-Response-Syndrome

Article	Year
Correspondence on 'Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort'. Annals of the rheumatic diseases, 2022, Volume: 81, Issue:11 Topics: Child; COVID-19; Humans; Kava; Mucocutaneous Lymph Node Syndrome; SARS-CoV-2; Systemic Inflammatory Response Syndrome	2022
Response to: 'Correspondence on 'Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID19): a multicentre cohort'' by Mastrolia Annals of the rheumatic diseases, 2022, Volume: 81, Issue:11 Topics: Child; COVID-19; Humans; Kava; Mucocutaneous Lymph Node Syndrome; SARS-CoV-2; Systemic Inflammatory Response Syndrome	2022
Acute cutaneous toxicity with kava: an inflammatory sebotropic reaction and urticaria. Clinical and experimental dermatology, 2020, Volume: 45, Issue:4 Topics: Acute Disease; Aftercare; Anti-Inflammatory Agents; Biopsy; Diagnosis, Differential; Erythema; Exanthema; Female; Humans; Kava; Plants, Medicinal; Prednisolone; Pruritus; Skin Diseases; Systemic Inflammatory Response Syndrome; Treatment Outcome; Urticaria; Young Adult	2020